Marie Asp - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Marie Asp

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Brain, Behavior, and Immunity|June 8, 2025

Add-on probiotics for inflammatory depression - A double-blind randomized placebo-controlled trialGustav Söderberg Veibäck, Jesper Lindahl, Klara Suneson, et al.

BMJ Open|November 30, 2023

Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, SwedenJesper Lindahl, Marie Asp, Darya Ståhl, et al.

Nature Medicine|June 12, 2026

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trialFilip Ventorp, Marie Asp, Sofia Olsson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Brain, Behavior, and Immunity|June 8, 2025

Add-on probiotics for inflammatory depression - A double-blind randomized placebo-controlled trialGustav Söderberg Veibäck, Jesper Lindahl, Klara Suneson, et al.

BMJ Open|November 30, 2023

Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, SwedenJesper Lindahl, Marie Asp, Darya Ståhl, et al.

Nature Medicine|June 12, 2026

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trialFilip Ventorp, Marie Asp, Sofia Olsson, et al.

Pageof 2